Author: Simon Mundy
Signs of broader-based growth as renewable energy investment falls in ChinaRead More
Clinical-stage cell therapy manufacturer Cellares has raised $257 million in a Series D round as it gears up commercially and prepares to go public.Read More
The Global Glioma Market is focused on managing gliomas, aggressive brain tumors from glial cells. Glioblastoma Multiforme (GBM) is the deadliest type, characterized by rapid growth and invasiveness. Early diagnosis and treatment are crucial for improving patient outcomes. The market is driven by rising glioma cases, advancing cancer therapies, and enhanced diagnostic tools. Challenges include drug resistance, high treatment costs, and complex regulatory issues. Leading companies like Merck & CoRead More
Starbucks reported a bigger-than-expected rise in first-quarter comparable sales on Wednesday, as demand rebounded in the U.S. after nearly two years in early signs of success of CEO Brian Niccol’s turnaround efforts.Read More
A large international study led by Mayo Clinic finds perimenopause is defined more by fatigue, mood and sleep issues than hot flashes.Read More
A 20-year-old woman is suing YouTube and Meta — TikTok and Snapchat settled with her out of court — alleging they designed their platforms to be addictive.Read More
As the S&P 500 reaches new heights and the tech-heavy Nasdaq experiences a robust rally, driven by strong performances in technology stocks, the U.S. market is buzzing with optimism despite mixed signals from other sectors like healthcare. In this environment of heightened interest in technology shares, investors are keenly watching high-growth tech stocks that have shown resilience and potential for expansion, making them intriguing options to consider amidst current economic dynamics.Read More
Brookfield Renewable has high-powered total return potential in 2026 and beyond.Read More
“We must stop legislating our classrooms into tech deserts and start treating them as places where students engage with technology thoughtfully, ethically and creatively,” Utah educator Kelli Cannon writes in an op-ed.Read More
CEO of Dutch giant ASML tempers expectations amid Brussels’ drive to reduce dependence on foreign powers.Read More